Jinling Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 21.60%

Jinling Pharmaceutical Co Ltd (000919) has an Asset Resilience Ratio of 21.60% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jinling Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.30 Billion

≈ $190.40 Million USD Cash + Short-term Investments

Total Assets

CN¥6.02 Billion

≈ $881.50 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (1999–2024)

This chart shows how Jinling Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Jinling Pharmaceutical Co Ltd (000919) total assets.

Liquid Assets Composition Over Time

This chart breaks down Jinling Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Jinling Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.30 Billion	21.6%
Total Liquid Assets	CN¥1.30 Billion	21.60%

Asset Resilience Insights

Good Liquidity Position: Jinling Pharmaceutical Co Ltd maintains a healthy 21.60% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Jinling Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jinling Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Jinling Pharmaceutical Co Ltd (1999–2024)

The table below shows the annual Asset Resilience Ratio data for Jinling Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	11.60%	CN¥706.05 Million ≈ $103.32 Million	CN¥6.09 Billion ≈ $890.99 Million	+9.78pp
2023-12-31	1.81%	CN¥82.57 Million ≈ $12.08 Million	CN¥4.55 Billion ≈ $665.88 Million	-0.22pp
2022-12-31	2.03%	CN¥92.35 Million ≈ $13.51 Million	CN¥4.54 Billion ≈ $664.84 Million	+2.00pp
2021-12-31	0.03%	CN¥1.25 Million ≈ $183.06K	CN¥4.45 Billion ≈ $650.83 Million	0.00pp
2020-12-31	0.03%	CN¥1.38 Million ≈ $201.35K	CN¥4.28 Billion ≈ $626.82 Million	-2.62pp
2019-12-31	2.65%	CN¥110.28 Million ≈ $16.14 Million	CN¥4.16 Billion ≈ $608.50 Million	+1.30pp
2018-12-31	1.35%	CN¥52.45 Million ≈ $7.67 Million	CN¥3.88 Billion ≈ $568.49 Million	-0.38pp
2017-12-31	1.73%	CN¥66.76 Million ≈ $9.77 Million	CN¥3.86 Billion ≈ $564.40 Million	+0.66pp
2016-12-31	1.08%	CN¥41.50 Million ≈ $6.07 Million	CN¥3.86 Billion ≈ $564.53 Million	-2.28pp
2015-12-31	3.36%	CN¥129.18 Million ≈ $18.90 Million	CN¥3.85 Billion ≈ $563.41 Million	-1.52pp
2014-12-31	4.87%	CN¥176.55 Million ≈ $25.83 Million	CN¥3.62 Billion ≈ $530.04 Million	+2.21pp
2013-12-31	2.66%	CN¥87.97 Million ≈ $12.87 Million	CN¥3.30 Billion ≈ $483.54 Million	+1.74pp
2012-12-31	0.93%	CN¥29.61 Million ≈ $4.33 Million	CN¥3.20 Billion ≈ $468.10 Million	-4.40pp
2011-12-31	5.33%	CN¥157.59 Million ≈ $23.06 Million	CN¥2.96 Billion ≈ $432.89 Million	-1.70pp
2010-12-31	7.02%	CN¥192.70 Million ≈ $28.20 Million	CN¥2.74 Billion ≈ $401.50 Million	-1.03pp
2009-12-31	8.05%	CN¥197.68 Million ≈ $28.93 Million	CN¥2.46 Billion ≈ $359.32 Million	+3.66pp
2008-12-31	4.39%	CN¥96.78 Million ≈ $14.16 Million	CN¥2.20 Billion ≈ $322.34 Million	-7.92pp
2007-12-31	12.31%	CN¥291.34 Million ≈ $42.63 Million	CN¥2.37 Billion ≈ $346.26 Million	+5.66pp
2006-12-31	6.65%	CN¥134.90 Million ≈ $19.74 Million	CN¥2.03 Billion ≈ $296.92 Million	+0.87pp
2005-12-31	5.78%	CN¥106.44 Million ≈ $15.58 Million	CN¥1.84 Billion ≈ $269.67 Million	-2.63pp
2004-12-31	8.40%	CN¥150.59 Million ≈ $22.04 Million	CN¥1.79 Billion ≈ $262.23 Million	-0.07pp
2003-12-31	8.48%	CN¥138.64 Million ≈ $20.29 Million	CN¥1.64 Billion ≈ $239.28 Million	-3.30pp
2002-12-31	11.78%	CN¥181.15 Million ≈ $26.51 Million	CN¥1.54 Billion ≈ $225.01 Million	-0.64pp
2001-12-31	12.42%	CN¥175.89 Million ≈ $25.74 Million	CN¥1.42 Billion ≈ $207.25 Million	-15.10pp
2000-12-31	27.52%	CN¥336.29 Million ≈ $49.21 Million	CN¥1.22 Billion ≈ $178.84 Million	+10.39pp
1999-12-31	17.13%	CN¥200.60 Million ≈ $29.35 Million	CN¥1.17 Billion ≈ $171.39 Million	--

pp = percentage points

About Jinling Pharmaceutical Co Ltd

SHE:000919 China Drug Manufacturers - Specialty & Generic

Market Cap

$587.91 Million

CN¥4.02 Billion CNY

Market Cap Rank

#11515 Global

#3265 in China

Share Price

CN¥6.46

Change (1 day)

-0.15%

52-Week Range

CN¥5.78 - CN¥8.91

All Time High

CN¥16.21